Uroprotective effect of diarylpropionitrile versus finasteride on rat model of testosterone-induced prostatic hyperplasia

Key Points

• Diarylpropionitrile effectively reduces prostatic hyperplasia associated with testosterone in rats, showing significant uroprotective effects.
• Key evidence indicates a noticeable decrease in prostatic enlargement measured within a 4-week treatment window.
• Experiments utilized a rat model to assess the impacts of diarylpropionitrile and finasteride on testosterone-induced changes.
• Findings highlight the potential for diarylpropionitrile as a new therapeutic option, although further studies are necessary.